MAPT and Alzheimer disease: When evaluating specifically insoluble Aβ and tau pathologies, there was a significant inverse correlation (p < 0.01 for both pathologies) to ACE2, such that higher degrees of AD pathology were associated with lower levels of ACE2 expression (Kehoe et al., 2016).